About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Ohio | 28,737 Studies Near You

Clinical TrialsOhio

Clinical Trials in Ohio

Discover 28,737 clinical trials near Ohio. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5501-5520 of 28,737 trials

CompletedCognitive Training TrialCurrently, only two treatment modalities for pediatric attention deficit hyperactivity disorder (ADHD) are considered evidence-based: (1) pharmacological and (2) behavioral…NCT01133418·Cincinnati, Ohio

Find Trials by Condition in Ohio

Breast Cancerin Ohio Lung Cancerin Ohio Prostate Cancerin Ohio Colorectal Cancerin Ohio Melanomain Ohio Leukemiain Ohio Lymphomain Ohio Pancreatic Cancerin Ohio Ovarian Cancerin Ohio Brain Cancerin Ohio Diabetesin Ohio

Data from ClinicalTrials.govTerms

CompletedComparison of Glenoid Position Using SmartBonesThe investigators propose a randomized clinical trial to evaluate the accuracy of glenoid implant placement comparing four groups of patients.NCT03035318·Cleveland, Ohio

TerminatedS9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's DiseaseRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00005090·Birmingham, Alabama and 46 others

TerminatedSafety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolar I DisorderThe primary purpose of this study is to determine whether ELND005 is effective in the maintenance treatment of bipolar 1 disorder when added to other therapies.NCT01674010·Birmingham, Alabama and 81 others

Active not recruitingA Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLCThis study is for patients with advanced/metastatic non-small cells lung cancer (NSCLC) who have not received any treatment through the vein for the advanced disease.NCT06246110·Daphne, Alabama and 37 others

CompletedEfficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of MigraineThis study will evaluate the efficacy, safety, and tolerability of 2 doses of ubrogepant (50 and 100 mg) compared to placebo for the acute treatment of a single migraine attack.NCT02828020·Mesa, Arizona and 89 others

TerminatedValidation of Low Dose CT for Diagnosis of UrolithiasisThe investigators have developed an extremely low dose renal computed tomography (CT) protocol that on preliminary testing has an effective dose in the range of a single view…NCT03656913·Cincinnati, Ohio

UnknownWeekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and PlatinumRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003160·Mobile, Alabama and 17 others

CompletedA Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.An open-label, multicenter, Phase 1b/2 study to identify the recommended Phase 2 dose and assess the efficacy and safety of BXCL701 administered orally, as monotherapy and in…NCT03910660·San Francisco, California and 11 others

CompletedPediatric Gastroparesis RegistryThe objective of the Pediatric Gastroparesis Registry is to create a national prospective registry of children and adolescents with gastroparesis and gastroparesis-like syndrome…NCT03680820·Boston, Massachusetts and 2 others

Active not recruitingA Pilot Study on Reverse Aging (The REVERSE Study)Aging can be defined as a time-dependent functional decline in physiological function, which may increase the vulnerability to diseases and eventually death.NCT07354620·Cincinnati, Ohio

RecruitingMedtronic Cardiac Surgery PMCF RegistryThis registry is being conducted to support ongoing post-market surveillance activities.NCT04073420·Marietta, Georgia and 25 others

CompletedSorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or BevacizumabRATIONALE: Sorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.NCT00866320·Cleveland, Ohio and 1 other

CompletedStudy of CD388 for the Prevention of Influenza in Subjects Not at Risk for Influenza ComplicationsThe purpose of this study is to evaluate the effectiveness of CD388 in preventing symptomatic laboratory-confirmed influenza infections, as compared to placebo, and to select a…NCT06609460·Anniston, Alabama and 56 others

CompletedHematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and FludarabineThis is a genetic disease (transmitted through the parents' genes) called Fanconi Anemia.NCT00987480·Boston, Massachusetts and 5 others

CompletedXenform Postmarket Surveillance StudyTo compare transvaginal repair with a biologic graft to traditional native tissue repair in women surgically treated for anterior and/or apical pelvic organ prolapse.NCT01945580·Orange, California and 24 others

CompletedStudy to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi SyndromeRGH-706 is a novel, potent, and orally active MCHR1 antagonist drug candidate discovered and being developed by Gedeon Richter Plc. for weight management.NCT05322096·San Diego, California and 22 others

CompletedA Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets.The objective of this study is to determine the effect of two dose strengths of dalfampridine-Extended Release (ER) tablets, taken twice daily for 12 weeks, on stable walking…NCT02271217·Gilbert, Arizona and 73 others

TerminatedA Study to Assess the Efficacy and Safety of Namilumab in Participants With Chronic Pulmonary SarcoidosisThis is a randomized, double-blind, placebo-controlled study with an open-label extension (OLE).NCT05314517·Birmingham, Alabama and 46 others

CompletedSafety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive DisorderThis study is to evaluate that (SEROQUEL®) quetiapine sustained-release is efficacious and safe in the treatment of patients with MDD.NCT00320268·Little Rock, Arkansas and 36 others

PreviousPage 276 of 1437Next

Heart Diseasein Ohio